IBEX secures £3.25m funding to transform osteoporosis diagnosis and care

IBEX Innovations Limited, the UK-based provider of advanced medical imaging software, is delighted to announce the completion of a £3.25m equity financing round from existing venture and corporate investors.

The funding will be used to drive market adoption of the innovative IBEX Trueview® software platform across medical X-ray imaging applications and to complete commercialisation of the unique Trueview bone health product which enables early population-wide diagnosis of osteoporosis from standard X-ray scans. Widespread adoption of Trueview has the potential to generate annual healthcare savings of £19bn and save 110,000 lives over an initial 10-year period.

Dr Neil Loxley, IBEX CEO commented:

“IBEX has made outstanding progress in product and market development in the past year despite the challenges presented by the COVID-19 pandemic. This funding will provide the company with the means to execute its ambitious plans and secure a leading position in the emerging bone health market. I am grateful for the continued support of the existing investors who participated in this round, and excited by the challenges and opportunities ahead.”

Get in touch

Trueview offers X-ray system manufacturers a rare opportunity to add significant value, increase margins and expand market share in the highly competitive and commoditised DR market.

IBEX is seeking partnerships with leading OEMs to bring the Trueview bone health product to market. Contact us today to discuss an evaluation on your systems.

Similar Posts